Li Ding
Impact in
- Immunology top 2%
- Immunodeficiency and Autoimmune Disorders
- Infectious Diseases top 2%
- Tuberculosis Research and Epidemiology
Papers in
-
- Extracellular vesicles in disease 17
-
- Nanoplatforms for cancer theranostics 25
- Co-authors
- Steven M. Holland (33 shared papers)Yu Chen (25 shared papers)Wei Feng (9 shared papers)Caihong Dong (8 shared papers)Meiqi Chang (14 shared papers)Yinghong Wang (1 shared paper)Wen Shi (1 shared paper)Hui Huang (6 shared papers)
- Journals
- Advanced Functional Materials (6 papers)Chinese Chemical Letters (5 papers)Annals of Translational Medicine (5 papers)Advanced Science (4 papers)Advanced Materials (4 papers)
- Partner nations
- ChinaUnited StatesBrazil
In The Last Decade
Li Ding
159 papers receiving 5.1k citations
Li Ding's Hit Papers
Peers
Comparison fields: 5 of 172
- Immunology 952
- Infectious Diseases 636
- Epidemiology 931
- Biomaterials 400
- Biomedical Engineering 1.1k
Countries citing papers authored by Li Ding
This map shows the geographic impact of Li Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Ding more than expected).
Fields of papers citing papers by Li Ding
This network shows the impact of papers produced by Li Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Ding. The network helps show where Li Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 168 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 231 | |
| 2 | 2018 | 198 | |
| 3 | 2013 | 192 | |
| 4 | 2017 | 175 | |
| 5 | 2017 | 160 | |
| 6 | 2005 | 156 | |
| 7 | 2012 | 135 | |
| 8 | 2020 | 121 | |
| 9 | 2021 | 116 | |
| 10 | 2010 | 112 | |
| 11 | 2006 | 107 | |
| 12 | 2016 | 88 | |
| 13 | 2021 | 88 | |
| 14 | 2006 | 87 | |
| 15 | 2021 | 85 | |
| 16 | 2018 | 76 | |
| 17 | 2022 | 75 | |
| 18 | 2006 | 75 | |
| 19 | Therapeutic effectiveness of bacteriophages in the rescue of mice with extended spectrum beta-lactamase-producing Escherichia coli bacteremia. | 2006 | 74 |
| 20 | 2003 | 68 |
About Li Ding
Li Ding is a scholar working on Molecular Biology, Biomedical Engineering, Epidemiology, Immunology and Pulmonary and Respiratory Medicine, having authored 168 papers that have together received 5.2k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (25 papers), Extracellular vesicles in disease (17 papers), Mycobacterium research and diagnosis (11 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (8 papers), Immunodeficiency and Autoimmune Disorders (8 papers), Advanced Nanomaterials in Catalysis (7 papers), Traditional Chinese Medicine Analysis (7 papers) and Inhalation and Respiratory Drug Delivery (6 papers). The work is most often cited by research in Immunology (952 citations), Infectious Diseases (636 citations), Epidemiology (931 citations), Biomaterials (400 citations) and Biomedical Engineering (1.1k citations). Li Ding has collaborated with scholars based in China, United States and Brazil. Frequent co-authors include Steven M. Holland, Yu Chen, Wei Feng, Caihong Dong, Meiqi Chang, Yinghong Wang, Wen Shi, Hui Huang, Jianlin Shi and Luodan Yu. Their work appears in journals such as Advanced Functional Materials, Chinese Chemical Letters, Annals of Translational Medicine, Advanced Science and Advanced Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.